Rosarium Health raises $6M to turn homes into care sites
What's the deal? Rosarium HealthDealroom has a profile for this one. Try Dealroom →, a startup that helps people age at home, has raised $6 million in seed funding and secured partnerships with several Medicaid and Medicare Advantage (MA) plans. The round was led by Kalos VenturesDealroom has a profile for this one. Try Dealroom →, with participation from ResilienceVCDealroom has a profile for this one. Try Dealroom →, Rock Health Capital, Symphonic Capital, American Family Insurance Institute for Corporate and Social Impact, Black Tech Nations Ventures, and The Council. In total, Rosarium has raised $9 million.
The company's platform coordinates the full lifecycle of home-based care — from in-home assessments by occupational and physical therapists, to home modification recommendations like fall prevention, to installations such as accessible ramps and stair lifts. It also handles automated documentation, prior authorisation, and claims submission.
Rosarium operates a network of more than 800 clinicians and 3,000 contractors across 34 states.
"We deliver and pay for healthcare in the home at scale, enabling individuals to age with dignity," said Cameron Carter, founder and chief executive officer. "We help turn the home into a reliable and comfortable site of care, rather than leaving families and providers to navigate a fragmented process on their own."
Why now? The US is in the midst of a demographic shift that's straining existing care infrastructure. As more Americans age into Medicare and Medicaid, demand for home-based alternatives to institutional care is surging. Health plans are increasingly looking for partners that can coordinate home modifications and clinical assessments in a single, reimbursable workflow — exactly what Rosarium offers.
The new MA and Medicaid partnerships signal that payers see value in preventing costly hospitalisations and nursing home admissions by investing in the home environment upfront.
What could go wrong? Scaling a network that spans clinicians, contractors, and payer integrations across 34 states is operationally complex. Reimbursement for home modifications remains inconsistent across plans and states, and any shifts in Medicaid or Medicare policy could affect demand. The company will also need to prove that its interventions reduce downstream costs convincingly enough to retain and expand payer contracts.
The signal: Rosarium Health's investor roster — spanning healthtech-focused funds like Rock Health Capital and impact-oriented backers like American Family Insurance Institute for Corporate and Social Impact — reflects growing conviction that home-based care infrastructure is a viable, scalable category rather than a niche. With $9 million raised and partnerships with Medicaid and MA plans already in place, Rosarium is moving beyond pilot-stage validation into payer-integrated operations across 34 states, a trajectory consistent with its Dealroom classification as an early growth-stage company.
Read more: medcitynews.com
